- Home
- CTNM vs GOOD Comparison
CTNM vs GOOD Comparison
Compare CTNM & GOOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CTNM | GOOD |
|---|---|---|
| Founded | 2009 | 2003 |
| Country | United States | United States |
| Employees | 41 | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 575.3M | 563.9M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | CTNM | GOOD |
|---|---|---|
| Price | $15.15 | $11.57 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $18.60 | $11.00 |
| AVG Volume (30 Days) | 281.1K | ★ 474.5K |
| Earning Date | 03-05-2026 | 02-18-2026 |
| Dividend Yield | N/A | ★ 10.35% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $155,250,000.00 |
| Revenue This Year | N/A | $8.62 |
| Revenue Next Year | N/A | $6.28 |
| P/E Ratio | ★ N/A | $63.28 |
| Revenue Growth | N/A | ★ 4.95 |
| 52 Week Low | $3.35 | $10.33 |
| 52 Week High | $15.92 | $16.40 |
Technical Indicators
Market Signals| Indicator | CTNM | GOOD |
|---|---|---|
| Relative Strength Index (RSI) | 65.79 | 56.54 |
| Support Level | $13.86 | $11.28 |
| Resistance Level | $15.47 | $11.69 |
| Average True Range (ATR) | 1.15 | 0.22 |
| MACD | 0.13 | -0.02 |
| Stochastic Oscillator | 78.93 | 56.59 |
Price Performance
Historical ComparisonAbout CTNM Contineum Therapeutics Inc.
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About GOOD Gladstone Commercial Corporation Real Estate Investment Trust
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.